StoneBridge Pharma, LLC

5 articles about StoneBridge Pharma, LLC

• Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights

  11/10/2021

  Xeris Biopharma Holdings, Inc. today announced financial results for the third quarter and first nine months ended September 30, 2021, and recent highlights, including the completion of the Strongbridge Biopharma plc acquisition on October 5, 2021.

• StoneBridge Pharma, LLC And Capellon Pharmaceuticals Announce Co-Promotion Agreement To Market Symax™ Duotab (Hyoscyamine Sulfate) For Irritable Bowel Syndrome

  10/12/2006

• Sykora Named StoneBridge Pharma, LLC President

  7/5/2006

• Innovex And StoneBridge Pharma, LLC Announce Parternship

  4/5/2006

• StoneBridge Pharma, LLC Release: New Pharmaceutical Company Pursues Overlooked Opportunities

  1/26/2006